International Patent: EFFECTOR T-CELL AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

GENEVA, July 31 -- NATIONAL CANCER CENTER filed a patent application (JP2026/002016) for “EFFECTOR T-CELL AND PHARMACEUTICAL COMPOSITION CONTAINING SAME”. With publication no. WO/2026/160421, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 5/10

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....